Health
A vaxxing problem: why aren’t more Australian companies producing vaccines? – Sydney Morning Herald
As global demand for vaccines remains massive, Australia’s currently idle manufacturing facilities could be repurposed in the fight against COVID-19.
Normal text sizeLarger text sizeVery large text size
In Melbourne, a manufacturing facility that could potentially be repurposed to help produce a COVID-19 vaccine sits idle. The facility owned by pharmaceutical company IDT Australia was opened in 2008 by then-premier John Brumby, and among the types of products made on its production line were antibiotics. But the facility fell into disuse as it became cheaper to manufacture medicines offshore.
In March, the federal Health Department asked IDT…
-
Business17 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News14 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
Business18 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business14 hours ago1 ASX dividend stock down 43% I’d buy right now